Skip to search formSkip to main contentSkip to account menu

Parietaria judaica pollen

Known as: Pollinex 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
An overview of short-term specific immunotherapy (ST-SIT) highlighting Pollinex Quattro (PQ) Tree is presented. The product… 
2005
2005
BACKGROUND Specific immunotherapy (SIT) is believed to modulate CD4+ T-helper cells. In order to improve safety, SIT vaccines are… 
2004
2004
A novel allergy vaccine (Pollinex® Quattro) has been developed for the prevention or relief of allergic symptoms caused by a… 
2001
2001
BACKGROUND Specific immunotherapy (SIT) is probably the only causative treatment in allergic diseases including pollinosis. It is… 
1995
1995
The clinical results of specific immunotheraphy using Pollinex, Catalet, or Alavac S-HDM vaccines in 22 patients with atopic… 
1988
1988
Thirty-five ragweed-sensitive patients received immunotherapy with either alum-precipitated aqueous extracts (AP) or modified… 
1987
1987
We investigated in grass-pollen-sensitive adults the efficacy and safety of a therapeutic hyposensitisation regimen consisting of… 
1986
1986
IgG antibody responses, induced by individual temperate grass pollen allergens in atopic subjects, have been studied by an SDS… 
1976
1976
Twenty-six patients from a general practice suffering with clear-cut seasonal rhinitis due to grass pollen were treated with 3…